AC Immune (ACIU) Total Current Liabilities (2014 - 2026)

AC Immune (ACIU) has reported Total Current Liabilities for 12 consecutive years, with $117.8 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Current Liabilities rose 106617.05% year-over-year to $117.8 billion; the TTM figure through Mar 2026 stood at $117.8 billion (up 106617.05% YoY), while the FY2025 annual figure was $114.2 billion, up 99120.86% from the prior year.
• Total Current Liabilities fell to $117.8 billion in Q1 2026 per ACIU's latest filing, from $118.5 billion in the prior quarter.
• Across five years, Total Current Liabilities topped out at $118.5 billion in Q4 2025 and bottomed at $11.6 million in Q1 2023.
• Historically, Total Current Liabilities has averaged $16.3 billion across 5 years, with a median of $115.1 million in 2024.
• Annual changes were most pronounced in 2022 — Total Current Liabilities sank 99.95% — and 2023, when it soared 128323.97%.
• AC Immune's Total Current Liabilities stood at $11.9 million in 2022, then surged by 128323.97% to $15.3 billion in 2023, then plunged by 99.25% to $115.1 million in 2024, then surged by 102826.14% to $118.5 billion in 2025, then decreased by 0.57% to $117.8 billion in 2026.
• Business Quant data shows ACIU's Total Current Liabilities at $117.8 billion in Q1 2026, $118.5 billion in Q4 2025, and $122.9 million in Q3 2025.